Dendritic Golgi as key cause of degenerative brain disease

August 11, 2017
This figure shows degeneration of dendritic-specific Golgi complex in the brain cells by accumulation of polyglutamine toxic protein in the nucleus and its mechanism of early neuropathy. A comparison of brain cell in normal (left) and brain cell (right) in patients with degenerative brain disease. The study has demonstrated for the first time in the world that the polyglutamine toxin protein accumulated in the nucleus of the brain cell inhibits the transcription factors CBP and CrebA. As a result, the dendritic-specific Golgi cannot be properly formed and causes the morphological transformation of the brain cell. Credit: DGIST

A joint research team of DGIST (Daegu Gyeongbuk Institute of Science and Technology) has identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases. They team's findings could accelerate the development of early neuropathy treatment for a variety of degenerative brain diseases, including dementia, Parkinson's disease and Lou Gehrig's disease, which are commonly known to be caused by toxic proteins.

The elderly population has grown with the advancement of medical technology. In Korea, one in 10 elderly people aged 65 or older in recent years suffers from dementia. With the increasing number of patients suffering from intractable degenerative brain , many studies have sought the development of .

Unfortunately, the patients who seek doctors for treatment of degenerative brain diseases are likely already to have significant damage to and it is difficult to expect an effective recovery via commercially available therapeutic agents. Therefore, it is essential to understand how degenerative brain disease progresses in the early stage.

The research teams led by Professor Sung Bae Lee and Professor Daehee Hwang have verified for the first time that dendritic-specific Golgi, a cellular organelle in neurons, plays a key role in the early of degenerative brain disease.

In a model of degenerative brain diseases caused by polyglutamine toxic protein such as Huntington's chorea and spinal cord cerebellar degeneration, the research teams found that the deformation or abnormality of dendritic-specific Golgi, which play a key role in the cell membrane of brain , is the major cause of degenerative brain disease leading to morphological transformation of neuronal cells.

The study has demonstrated that the early neuropathy of diseased brain cells can be restored by inducing overexpression of the CrebA gene, a newly discovered key factor in pathology. In addition, by identifying the transcription factors involved in the early neuropathy caused by toxic proteins such as CrebA and high-level factor CBP, the researchers have suggested that they could be new subjects to develop therapeutic agents for degenerative brain diseases.

DGIST Professor Sung Bae Lee said, "We have verified that the dendrite-specific Golgi of brain cells play a core role in the early neuropathy of . By restoring the early stages of the disease, we expect to accelerate the development of therapeutic drugs that can effectively treat degenerative diseases."

This study has been published in the online edition of Cell Reports, an international journal of life science and the sister journal of Cell, on July 11.

Explore further: Discovery may offer hope to Parkinson's disease patients

More information: Chang Geon Chung et al, Golgi Outpost Synthesis Impaired by Toxic Polyglutamine Proteins Contributes to Dendritic Pathology in Neurons, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.06.059

Related Stories

Discovery may offer hope to Parkinson's disease patients

May 22, 2017
The finding of a common protein abnormality in these degenerative diseases supports a hypothesis among experts that abnormal deposition of proteins in many neurodegenerative disorders reflects an early change in these proteins.

Connection between brain inflammation and CTE identified

November 2, 2016
For the first time, researchers have shown that inflammation in the brain may have direct involvement in the development of chronic traumatic encephalopathy (CTE). In addition, they found that the number of years one plays ...

Team identifies mechanism of dopaminergic neuronal death inhibition using stress hormone cortisol

April 26, 2017
DGIST's research team has found a candidate substance that can prevent and cure Parkinson's disease. By using this substance, the team also has identified the mechanism of dopaminergic neuronal death inhibition.

Researchers identify potential treatment for type of muscle and brain degenerative disease

March 21, 2017
UCLA researchers have discovered the molecular basis of, and identified potential treatment for, an incurable disease known as inclusion body myopathy, Paget disease with frontotemporal dementia, or IBMPFD. Using both genetically ...

Researchers reveal how neurodegenerative diseases spread through the brain

November 9, 2016
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain. This the main conclusion ...

New hope for early diagnosis and treatment of Parkinson's

February 15, 2013
Flinders University researchers have discovered that a protein in the brain may play a role in the development of Parkinson's disease – a common degenerative neurological disorder which affects the control of body movements.

Recommended for you

Now you like it, now you don't: Brain stimulation can change how much we enjoy and value music

November 20, 2017
Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, ...

Schizophrenia originates early in pregnancy, 'mini-brain' research suggests

November 20, 2017
Symptoms of schizophrenia usually appear in adolescence or young adulthood, but new research reveals that the brain disease likely begins very early in development, toward the end of the first trimester of pregnancy. The ...

Deletion of a stem cell factor promotes TBI recovery in mice

November 20, 2017
UT Southwestern molecular biologists today report the unexpected finding that selectively deleting a stem cell transcription factor in adult mice promotes recovery after traumatic brain injury (TBI).

Brain cell advance brings hope for Creutzfeldt-Jakob disease

November 20, 2017
Scientists have developed a new system to study Creutzfeldt-Jakob disease in the laboratory, paving the way for research to find treatments for the fatal brain disorder.

MRI uncovers brain abnormalities in people with depression and anxiety

November 20, 2017
Researchers using MRI have discovered a common pattern of structural abnormalities in the brains of people with depression and social anxiety, according to a study presented being next week at the annual meeting of the Radiological ...

Theory: Flexibility is at the heart of human intelligence

November 19, 2017
Centuries of study have yielded many theories about how the brain gives rise to human intelligence. Some neuroscientists think intelligence springs from a single region or neural network. Others argue that metabolism or the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.